NeuVax vaccine

Phase 2

Insight Molecular Diagnostics Inc. (IMDX)

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

12 competitors in Breast Cancer

AZNcapivasertib

MRKpembrolizumab

RHHBYtrastuzumab (Herceptin®)

Drug Information

Target Indication

Breast Cancer

Clinical Trial

NCT02297698

Last updated: 1/22/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Source: FDA Orange Book

Drug Science

Mechanism of action & safety profile

Developer

IMDX

Insight Molecular Diagnostics Inc.

In Vitro & In Vivo Diagnostic Substances•North America•NASDAQ

Related Pipeline

99mTc-MIP-1404 InjectionPhase 3

Prostate Cancer

Klarity CL, Cylcosporine 0.1%/Loteprednol Etabonate 0.2% Preservative FreePhase 3

Dry Eye

Drug: 99mTc-MIP-1404Phase 2

Prostate Cancer

UltratraceTM Iobenguane I 131 ImagingPhase 2

Neuroblastoma

Iodofiltic acid I 123Phase 2

Acute Coronary Syndrome

View full pipeline

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts